These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4438830)

  • 21. Evaluation of the hypothermic action of tetrahydrocannabinols in mice and squirrel monkeys.
    Haavik CO; Hardman HF
    J Pharmacol Exp Ther; 1973 Dec; 187(3):568-74. PubMed ID: 4203720
    [No Abstract]   [Full Text] [Related]  

  • 22. On the pharmacology of marihuana.
    Gershon S
    Behav Neuropsychiatry; 1970 Jan; 1(10):9-18. PubMed ID: 4908416
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid depletion of adrenal epinephrine and elevation of telencephalic serotonin by (-)-trans- 9 -tetrahydrocannabinol in mice.
    Welch BL; Welch AS; Messiha FS; Berger HJ
    Res Commun Chem Pathol Pharmacol; 1971 May; 2(3):382-91. PubMed ID: 5149894
    [No Abstract]   [Full Text] [Related]  

  • 24. An experimental analysis of behavioral factors in drug dependence.
    Thompson T; Pickens R
    Fed Proc; 1975 Aug; 34(9):1759-70. PubMed ID: 1097265
    [No Abstract]   [Full Text] [Related]  

  • 25. A behavioral analysis of aggressive behaviors induced and modulated by delta9-tetrahydrocannabinol, pilocarpine, d-amphetamine and l-dopa [proceedings].
    Miczek KA
    Act Nerv Super (Praha); 1977 Sep; 19(3):224-5. PubMed ID: 562581
    [No Abstract]   [Full Text] [Related]  

  • 26. Cannabidiol interaction with delta9-tetrahydrocannabinol.
    Borgen LA; Davis WM
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):663-70. PubMed ID: 4828762
    [No Abstract]   [Full Text] [Related]  

  • 27. The changes in vitamin B6 and brain amine metabolism in mice chronically treated with delta-9-tetrahydrocannabinol.
    Colombini CE; Westfall TC; McCoy EE
    Act Nerv Super (Praha); 1974 Mar; 16(1):68-9. PubMed ID: 4454949
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of fenfluramine with d-amphetamine-induced excitatory behaviour and hyperthermia.
    Jonsson J; Gunne LM
    Eur J Pharmacol; 1972 Jul; 19(1):52-5. PubMed ID: 5048662
    [No Abstract]   [Full Text] [Related]  

  • 29. Antagonism of the effects of delta 9-tetrahydrocannabinol by pemoline (Cylert-4).
    Howes JF
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):901-8. PubMed ID: 4796839
    [No Abstract]   [Full Text] [Related]  

  • 30. General and behavioral pharmacology.
    Harris LS
    Pharmacol Rev; 1971 Dec; 23(4):285-94. PubMed ID: 4943947
    [No Abstract]   [Full Text] [Related]  

  • 31. A paradoxical effect for 1 -tetrahydrocannabinol on rectal temperature in rats.
    Sofia RD
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):281-8. PubMed ID: 5074527
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of delta9-tetrahydrocannabinol and cannabinol on operant performance in rats.
    Karniol IG; Takahashi RN; Musty RE
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):230-7. PubMed ID: 4447406
    [No Abstract]   [Full Text] [Related]  

  • 33. 2-Phenylethylamine as a possible mediator for delta9-tetrahydrocannabinol-induced stimulation.
    Sabelli HC; Vazquez AJ; Mosnaim AD; Madrid-Pedemonte L
    Nature; 1974 Mar; 248(5444):144-5. PubMed ID: 4274244
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of cannabis on the conditioned alimentary motor reflex in cats.
    Navrátil J; Medek A; Hrbek J; Krejcí Z; Komenda S; Dvorák M
    Act Nerv Super (Praha); 1972; 14(2):109-10. PubMed ID: 5040148
    [No Abstract]   [Full Text] [Related]  

  • 35. Structure-activity relationships in the tetrahydrocannabinol series. Modifications on the aromatic ring and it the side-chain.
    Edery H; Grunfeld Y; Porath G; Ben-Zvi Z; Shani A; Mechoulam R
    Arzneimittelforschung; 1972 Nov; 22(11):1995-2003. PubMed ID: 4633591
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions between delta9-tetrahydrocannabinol and phencyclidine in rats and mice.
    Murray TF; Craigmill AL
    Proc West Pharmacol Soc; 1976; 19():362-8. PubMed ID: 996007
    [No Abstract]   [Full Text] [Related]  

  • 37. Central nervous system actions of some synthetic tetrahydrocannabinol derivatives.
    Domino EF; Hardman HF; Seevers MH
    Pharmacol Rev; 1971 Dec; 23(4):317-36. PubMed ID: 5003209
    [No Abstract]   [Full Text] [Related]  

  • 38. Some behavioral effects of delta9 -tetrahydrocannabinol in rats.
    Pradhan SN; Bailey PT; Ghosh B
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):197-204. PubMed ID: 4610672
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of 9 -tetrahydrocannabinol on a cholinergic-induced activation of the electroencephalogram in the rabbit.
    Consroe PF
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):705-12. PubMed ID: 4701266
    [No Abstract]   [Full Text] [Related]  

  • 40. [Subjective changes with delta 9 trans-tetrahydrocannabinol in cannabis naive subjects].
    Dittrich A; Woggon B
    Int Pharmacopsychiatry; 1974; 9(3):138-51. PubMed ID: 4609941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.